These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19596117)
1. Long-term follow-up results of breast cancer patients with sentinel lymph node biopsy using periareolar injection. Imasato M; Shimazu K; Tamaki Y; Taguchi T; Tanji Y; Kim SJ; Noguchi S Am J Surg; 2010 Apr; 199(4):442-6. PubMed ID: 19596117 [TBL] [Abstract][Full Text] [Related]
2. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
3. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
4. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla? Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472 [TBL] [Abstract][Full Text] [Related]
5. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
6. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
7. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
8. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958 [TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Reitsamer R; Peintinger F; Rettenbacher L; Prokop E J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556 [TBL] [Abstract][Full Text] [Related]
11. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
13. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up. Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458 [TBL] [Abstract][Full Text] [Related]
14. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J; Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in breast cancer: five years experience from Denmark. Christiansen P; Friis E; Balslev E; Jensen D; Møller S; Acta Oncol; 2008; 47(4):561-8. PubMed ID: 18465323 [TBL] [Abstract][Full Text] [Related]
16. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087 [TBL] [Abstract][Full Text] [Related]
17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
18. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534 [TBL] [Abstract][Full Text] [Related]
19. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer. Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740 [TBL] [Abstract][Full Text] [Related]
20. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years. Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]